Alpine Global Management, LLC Immunovant, Inc. Transaction History

Alpine Global Management, LLC

$331 Million
Q3 2024

A detailed history of Alpine Global Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Alpine Global Management, LLC holds 1,882,704 shares of IMVT stock, worth $51.8 Million. This represents 15.65% of its overall portfolio holdings.

Number of Shares

1,882,704

Previous 1,907,704 1.31%

Holding current value

$51.8 Million

Previous $50.4 Million 2.84%

% of portfolio

15.65%

Previous 11.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.51 - $27.51 $687,750 - $687,750	-25,000 Reduced 1.31%	1,882,704 $51.8 Million
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $627,500 - $790,250	25,000 Added 1.33%	1,907,704 $50.4 Million
Q1 2024 May 15, 2024	BUY	$30.27 - $43.79 $14.7 Million - $21.2 Million	484,332 Added 34.64%	1,882,704 $60.8 Million
Q4 2023 Aug 06, 2024	BUY	$31.31 - $44.19 $4.57 Million - $6.45 Million	145,898 Added 11.65%	1,398,372 $58.9 Million
Q4 2023 Feb 12, 2024	BUY	$31.31 - $44.19 $4.57 Million - $6.45 Million	145,898 Added 11.65%	1,398,372 $58.9 Million
Q3 2023 Aug 06, 2024	SELL	$18.55 - $39.96 $3.47 Million - $7.48 Million	-187,070 Reduced 13.0%	1,252,474 $48.1 Million
Q3 2023 Nov 21, 2023	SELL	$18.55 - $39.96 $3.47 Million - $7.48 Million	-187,070 Reduced 13.0%	1,252,474 $48.1 Million
Q3 2023 Nov 14, 2023	SELL	$18.55 - $39.96 $3.47 Million - $7.48 Million	-187,070 Reduced 13.0%	1,252,474 $48.1 Million
Q2 2023 Aug 06, 2024	SELL	$14.2 - $23.75 $6.29 Million - $10.5 Million	-443,160 Reduced 23.54%	1,439,544 $27.3 Million
Q1 2023 Nov 21, 2023	BUY	$15.27 - $19.72 $2.86 Million - $3.69 Million	187,070 Added 14.94%	1,439,544 $22.3 Million
Q1 2023 May 15, 2023	SELL	$15.27 - $19.72 $923,163 - $1.19 Million	-60,456 Reduced 4.03%	1,439,544 $22.3 Million
Q4 2022 Feb 14, 2023	SELL	$6.59 - $17.75 $18.8 Million - $50.6 Million	-2,848,017 Reduced 65.5%	1,500,000 $26.6 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $17.1 Million - $27.7 Million	4,348,017 New	4,348,017 $24.3 Million
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.65 $1.98 Million - $3.31 Million	586,228 Added 15.18%	4,448,017 $17.3 Million
Q1 2022 May 13, 2022	BUY	$5.06 - $8.77 $4.33 Million - $7.5 Million	854,789 Added 28.43%	3,861,789 $21.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $51,310 - $65,240	7,000 Added 0.23%	3,007,000 $25.6 Million
Q3 2021 Nov 12, 2021	SELL	$7.01 - $11.37 $1,402 - $2,274	-200 Reduced 0.01%	3,000,000 $26 Million
Q3 2021 Nov 12, 2021	BUY	$7.01 - $11.37 $7.01 Million - $11.4 Million	1,000,200 Added 50.01%	3,000,200 $26.1 Million
Q2 2021 Aug 13, 2021	BUY	$9.4 - $16.85 $8.49 Million - $15.2 Million	903,022 Added 82.32%	2,000,000 $21.1 Million
Q1 2021 May 13, 2021	BUY	$13.08 - $49.6 $14.3 Million - $54.4 Million	1,096,978 New	1,096,978 $17.6 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Account

Alpine Global Management, LLC Immunovant, Inc. Transaction History